Rank | Gene Set | Z-score |
---|---|---|
1 | negative T cell selection (GO:0043383) | 8.25621477 |
2 | negative thymic T cell selection (GO:0045060) | 7.73389320 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.55364431 |
4 | positive T cell selection (GO:0043368) | 7.09594576 |
5 | positive thymic T cell selection (GO:0045059) | 7.01809701 |
6 | regulation of isotype switching to IgG isotypes (GO:0048302) | 7.01093794 |
7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.93389015 |
8 | negative regulation of cell killing (GO:0031342) | 6.87973743 |
9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.87973743 |
10 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.72777039 |
11 | thymic T cell selection (GO:0045061) | 6.62415022 |
12 | T cell selection (GO:0045058) | 6.49726925 |
13 | response to interleukin-15 (GO:0070672) | 6.47394453 |
14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.28492538 |
15 | regulation of gamma-delta T cell activation (GO:0046643) | 6.25453143 |
16 | cellular response to interleukin-15 (GO:0071350) | 6.08212098 |
17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.01267015 |
18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.01267015 |
19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.88896348 |
20 | tolerance induction (GO:0002507) | 5.48885170 |
21 | activated T cell proliferation (GO:0050798) | 5.27947614 |
22 | * T cell receptor signaling pathway (GO:0050852) | 5.24453846 |
23 | regulation of T cell tolerance induction (GO:0002664) | 5.23231890 |
24 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 5.06820329 |
25 | T cell costimulation (GO:0031295) | 5.00625946 |
26 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.96915909 |
27 | lymphocyte costimulation (GO:0031294) | 4.94776462 |
28 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.90596727 |
29 | T cell migration (GO:0072678) | 4.87765057 |
30 | positive regulation of isotype switching (GO:0045830) | 4.84824489 |
31 | leukocyte aggregation (GO:0070486) | 4.80513634 |
32 | regulation of regulatory T cell differentiation (GO:0045589) | 4.76857538 |
33 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.75374320 |
34 | * interferon-gamma production (GO:0032609) | 4.72604441 |
35 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.68492898 |
36 | positive regulation of granulocyte differentiation (GO:0030854) | 4.64438356 |
37 | positive regulation of interleukin-2 production (GO:0032743) | 4.56444836 |
38 | negative regulation of T cell mediated immunity (GO:0002710) | 4.52799322 |
39 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.44565338 |
40 | positive regulation of B cell mediated immunity (GO:0002714) | 4.44565338 |
41 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.44239849 |
42 | regulation of isotype switching (GO:0045191) | 4.38311826 |
43 | positive regulation of tolerance induction (GO:0002645) | 4.29995357 |
44 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.24552909 |
45 | * antigen receptor-mediated signaling pathway (GO:0050851) | 4.23985870 |
46 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.18595948 |
47 | positive regulation of DNA recombination (GO:0045911) | 4.18154877 |
48 | positive regulation of humoral immune response (GO:0002922) | 4.14940898 |
49 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.11361731 |
50 | regulation of immunoglobulin mediated immune response (GO:0002889) | 4.06390663 |
51 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.99963038 |
52 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.99963038 |
53 | regulation of chronic inflammatory response (GO:0002676) | 3.98717447 |
54 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.93452971 |
55 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.93452971 |
56 | regulation of B cell mediated immunity (GO:0002712) | 3.91571432 |
57 | regulation of immunoglobulin production (GO:0002637) | 3.79144001 |
58 | positive regulation of immunoglobulin production (GO:0002639) | 3.77568601 |
59 | regulation of B cell differentiation (GO:0045577) | 3.77566452 |
60 | regulation of tolerance induction (GO:0002643) | 3.73246795 |
61 | regulation of interleukin-2 production (GO:0032663) | 3.72850306 |
62 | * T cell differentiation (GO:0030217) | 3.70347173 |
63 | NIK/NF-kappaB signaling (GO:0038061) | 3.65765389 |
64 | regulation of response to interferon-gamma (GO:0060330) | 3.61431020 |
65 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.61002478 |
66 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.60917107 |
67 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.60347628 |
68 | mast cell activation (GO:0045576) | 3.54777835 |
69 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.52516912 |
70 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.51638523 |
71 | * alpha-beta T cell activation (GO:0046631) | 3.50348284 |
72 | * alpha-beta T cell differentiation (GO:0046632) | 3.50291878 |
73 | Peyers patch development (GO:0048541) | 3.49401404 |
74 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.49401404 |
75 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.49182329 |
76 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.48640467 |
77 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.48627421 |
78 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.47834038 |
79 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.46361937 |
80 | B cell receptor signaling pathway (GO:0050853) | 3.42966517 |
81 | positive regulation of cell killing (GO:0031343) | 3.41437675 |
82 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.33753253 |
83 | positive regulation of B cell differentiation (GO:0045579) | 3.31558555 |
84 | regulation of cell killing (GO:0031341) | 3.31518277 |
85 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.29833512 |
86 | * T cell activation (GO:0042110) | 3.28306647 |
87 | positive regulation of T cell cytokine production (GO:0002726) | 3.26612763 |
88 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.25348619 |
89 | T-helper cell differentiation (GO:0042093) | 3.24899796 |
90 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.24899796 |
91 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.24806541 |
92 | T cell homeostasis (GO:0043029) | 3.24789117 |
93 | response to type I interferon (GO:0034340) | 3.21527092 |
94 | cellular response to type I interferon (GO:0071357) | 3.21357854 |
95 | type I interferon signaling pathway (GO:0060337) | 3.21357854 |
96 | T cell proliferation (GO:0042098) | 3.19131377 |
97 | T cell differentiation involved in immune response (GO:0002292) | 3.18535076 |
98 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.18535076 |
99 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.18535076 |
100 | negative regulation of adaptive immune response (GO:0002820) | 3.16673507 |
101 | leukocyte cell-cell adhesion (GO:0007159) | 3.15537025 |
102 | positive regulation of T cell activation (GO:0050870) | 3.15089500 |
103 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.14943086 |
104 | regulation of defense response to virus by virus (GO:0050690) | 3.14616590 |
105 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.11335003 |
106 | natural killer cell activation (GO:0030101) | 3.11233032 |
107 | lymphocyte migration (GO:0072676) | 3.10479213 |
108 | regulation of granulocyte differentiation (GO:0030852) | 3.07032125 |
109 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.06455126 |
110 | positive regulation of alpha-beta T cell activation (GO:0046635) | 3.05861716 |
111 | myeloid dendritic cell activation (GO:0001773) | 3.04173186 |
112 | negative regulation of interleukin-12 production (GO:0032695) | 3.04154296 |
113 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.01370287 |
114 | regulation of alpha-beta T cell activation (GO:0046634) | 3.01306375 |
115 | lymph node development (GO:0048535) | 3.00129650 |
116 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.99841908 |
117 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.99319826 |
118 | hepatocyte apoptotic process (GO:0097284) | 2.98220175 |
119 | positive regulation of T cell differentiation (GO:0045582) | 2.96748696 |
120 | natural killer cell differentiation (GO:0001779) | 2.96663584 |
121 | cellular response to interleukin-4 (GO:0071353) | 2.96487506 |
122 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.96467817 |
123 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.93831642 |
124 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.92841933 |
125 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.92841933 |
126 | cellular extravasation (GO:0045123) | 2.91531883 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 9.32683997 |
2 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.82693677 |
3 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.28469705 |
4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.05396845 |
5 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.94539211 |
6 | MYC_22102868_ChIP-Seq_BL_Human | 3.92970747 |
7 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.63284266 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.55051516 |
9 | MYB_26560356_Chip-Seq_TH2_Human | 3.47391480 |
10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.23885294 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.18046034 |
12 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.14495209 |
13 | MAF_26560356_Chip-Seq_TH1_Human | 3.05833425 |
14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.03733333 |
15 | MYB_26560356_Chip-Seq_TH1_Human | 2.88639040 |
16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.79273245 |
17 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.77848330 |
18 | UTX_26944678_Chip-Seq_JUKART_Human | 2.75798645 |
19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.72023560 |
20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.33447982 |
21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.32863560 |
22 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.31764915 |
23 | MAF_26560356_Chip-Seq_TH2_Human | 2.19670279 |
24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.18330310 |
25 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.17172823 |
26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.14145651 |
27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01423274 |
28 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.90328826 |
29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.83659648 |
30 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.83535273 |
31 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.83380198 |
32 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81831716 |
33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80196585 |
34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.77799289 |
35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.73996498 |
36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.73050960 |
37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.62460700 |
38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60553344 |
39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.59677871 |
40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.57377469 |
41 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.56208620 |
42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55976585 |
43 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.55799924 |
44 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.54723766 |
45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.52914648 |
46 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.51531309 |
47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.44698358 |
48 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.42430728 |
49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.40296355 |
50 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.36216358 |
51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31459260 |
52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31186015 |
53 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.28459261 |
54 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25295423 |
55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.24207782 |
56 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.24029721 |
57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24000453 |
58 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.19451813 |
59 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17001155 |
60 | SPI1_23127762_ChIP-Seq_K562_Human | 1.16378669 |
61 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.16076712 |
62 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.13832965 |
63 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.12706022 |
64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08937615 |
65 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07728396 |
66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06637546 |
67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06027954 |
68 | GATA3_26560356_Chip-Seq_TH1_Human | 1.04727554 |
69 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.04423159 |
70 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.01894535 |
71 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.00667607 |
72 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98794439 |
73 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97767954 |
74 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.97624694 |
75 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.97511598 |
76 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.93413198 |
77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93150937 |
78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92674395 |
79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92083961 |
80 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.90910779 |
81 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90046230 |
82 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.88308228 |
83 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88138563 |
84 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.87238836 |
85 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84425699 |
86 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.83930580 |
87 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.83494208 |
88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83436351 |
89 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83341385 |
90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.82721906 |
91 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.82552967 |
92 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82019457 |
93 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.81276532 |
94 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.80990960 |
95 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79682803 |
96 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78638319 |
97 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.74721223 |
98 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.74353995 |
99 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.74031357 |
100 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.73797872 |
101 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.73129511 |
102 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.72717291 |
103 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72120612 |
104 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.72088769 |
105 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.71478568 |
106 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.71298770 |
107 | * TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.71268102 |
108 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.71059152 |
109 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.71028606 |
110 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70867356 |
111 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.70682949 |
112 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.69655458 |
113 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.66816034 |
114 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.66361592 |
115 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.66361249 |
116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.65765492 |
117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.65117783 |
118 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.64490003 |
119 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.64087538 |
120 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.62721351 |
121 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.61608194 |
122 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.61186243 |
123 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.61012849 |
124 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.60866791 |
125 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60398728 |
126 | GATA2_19941826_ChIP-Seq_K562_Human | 0.59661775 |
127 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.58979753 |
128 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.58590622 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003763_abnormal_thymus_physiology | 6.19638492 |
2 | MP0005671_abnormal_response_to | 4.58351061 |
3 | MP0000685_abnormal_immune_system | 3.83821621 |
4 | * MP0001800_abnormal_humoral_immune | 3.10783925 |
5 | MP0009333_abnormal_splenocyte_physiolog | 3.02642911 |
6 | MP0001835_abnormal_antigen_presentation | 3.01649120 |
7 | MP0005387_immune_system_phenotype | 3.01553315 |
8 | MP0001790_abnormal_immune_system | 3.01553315 |
9 | MP0002166_altered_tumor_susceptibility | 2.99009389 |
10 | MP0005000_abnormal_immune_tolerance | 2.96360273 |
11 | MP0003300_gastrointestinal_ulcer | 2.91720576 |
12 | * MP0000703_abnormal_thymus_morphology | 2.79897736 |
13 | * MP0002398_abnormal_bone_marrow | 2.78842667 |
14 | MP0003436_decreased_susceptibility_to | 2.73463222 |
15 | * MP0002723_abnormal_immune_serum | 2.73229493 |
16 | MP0002405_respiratory_system_inflammati | 2.72907338 |
17 | * MP0002420_abnormal_adaptive_immunity | 2.70025295 |
18 | MP0001873_stomach_inflammation | 2.69664570 |
19 | * MP0001819_abnormal_immune_cell | 2.66247221 |
20 | MP0002006_tumorigenesis | 2.57009138 |
21 | MP0009785_altered_susceptibility_to | 2.54157701 |
22 | MP0006082_CNS_inflammation | 2.43847202 |
23 | * MP0002452_abnormal_antigen_presenting | 2.42434403 |
24 | MP0003866_abnormal_defecation | 2.40716344 |
25 | * MP0000716_abnormal_immune_system | 2.39002460 |
26 | MP0003303_peritoneal_inflammation | 2.33359294 |
27 | MP0002722_abnormal_immune_system | 2.31644910 |
28 | MP0010155_abnormal_intestine_physiology | 2.31308161 |
29 | MP0004947_skin_inflammation | 2.26742325 |
30 | MP0000689_abnormal_spleen_morphology | 2.19328432 |
31 | MP0002396_abnormal_hematopoietic_system | 2.18892860 |
32 | * MP0005025_abnormal_response_to | 2.16757454 |
33 | MP0003724_increased_susceptibility_to | 2.11208633 |
34 | MP0002933_joint_inflammation | 2.09009613 |
35 | MP0004510_myositis | 2.05903089 |
36 | * MP0002429_abnormal_blood_cell | 1.92030789 |
37 | MP0002148_abnormal_hypersensitivity_rea | 1.82275468 |
38 | MP0001853_heart_inflammation | 1.78653559 |
39 | MP0001845_abnormal_inflammatory_respons | 1.66877193 |
40 | MP0002419_abnormal_innate_immunity | 1.60290234 |
41 | MP0004808_abnormal_hematopoietic_stem | 1.59956411 |
42 | MP0004381_abnormal_hair_follicle | 1.45578271 |
43 | MP0005310_abnormal_salivary_gland | 1.43688542 |
44 | MP0005464_abnormal_platelet_physiology | 1.39027429 |
45 | MP0000858_altered_metastatic_potential | 1.38833569 |
46 | MP0000465_gastrointestinal_hemorrhage | 1.35343339 |
47 | MP0002009_preneoplasia | 1.29746413 |
48 | MP0000569_abnormal_digit_pigmentation | 1.27565628 |
49 | MP0000490_abnormal_crypts_of | 1.22977217 |
50 | MP0002132_abnormal_respiratory_system | 1.22626318 |
51 | MP0001533_abnormal_skeleton_physiology | 1.22302209 |
52 | MP0003448_altered_tumor_morphology | 1.20000377 |
53 | MP0008961_abnormal_basal_metabolism | 1.19607928 |
54 | MP0002138_abnormal_hepatobiliary_system | 1.14156764 |
55 | MP0001851_eye_inflammation | 1.07425403 |
56 | MP0005397_hematopoietic_system_phenotyp | 1.03235076 |
57 | MP0001545_abnormal_hematopoietic_system | 1.03235076 |
58 | MP0002019_abnormal_tumor_incidence | 1.00659526 |
59 | MP0004130_abnormal_muscle_cell | 1.00503858 |
60 | MP0002998_abnormal_bone_remodeling | 1.00381886 |
61 | MP0008057_abnormal_DNA_replication | 1.00110153 |
62 | MP0008469_abnormal_protein_level | 0.97933834 |
63 | MP0002163_abnormal_gland_morphology | 0.94665953 |
64 | MP0010352_gastrointestinal_tract_polyps | 0.93566091 |
65 | MP0003172_abnormal_lysosome_physiology | 0.91648610 |
66 | MP0005075_abnormal_melanosome_morpholog | 0.89350179 |
67 | MP0005076_abnormal_cell_differentiation | 0.87242789 |
68 | MP0004883_abnormal_blood_vessel | 0.82213358 |
69 | MP0001986_abnormal_taste_sensitivity | 0.80561864 |
70 | MP0001919_abnormal_reproductive_system | 0.79619080 |
71 | MP0008877_abnormal_DNA_methylation | 0.76482761 |
72 | MP0005023_abnormal_wound_healing | 0.75414539 |
73 | MP0001348_abnormal_lacrimal_gland | 0.74010713 |
74 | MP0009278_abnormal_bone_marrow | 0.73898236 |
75 | MP0003828_pulmonary_edema | 0.73550436 |
76 | MP0000015_abnormal_ear_pigmentation | 0.71053065 |
77 | MP0001881_abnormal_mammary_gland | 0.68175510 |
78 | MP0003077_abnormal_cell_cycle | 0.67590648 |
79 | MP0008260_abnormal_autophagy | 0.65016107 |
80 | MP0001243_abnormal_dermal_layer | 0.64849893 |
81 | MP0001663_abnormal_digestive_system | 0.64243137 |
82 | MP0009765_abnormal_xenobiotic_induced | 0.64068919 |
83 | MP0003795_abnormal_bone_structure | 0.64047428 |
84 | MP0000609_abnormal_liver_physiology | 0.63861102 |
85 | MP0008007_abnormal_cellular_replicative | 0.63769157 |
86 | MP0001501_abnormal_sleep_pattern | 0.61672080 |
87 | MP0009763_increased_sensitivity_to | 0.61245317 |
88 | MP0000604_amyloidosis | 0.57991385 |
89 | MP0000477_abnormal_intestine_morphology | 0.57895604 |
90 | MP0002822_catalepsy | 0.56891633 |
91 | MP0003453_abnormal_keratinocyte_physiol | 0.55444402 |
92 | MP0001216_abnormal_epidermal_layer | 0.55410857 |
93 | MP0003646_muscle_fatigue | 0.54870204 |
94 | MP0000372_irregular_coat_pigmentation | 0.54453696 |
95 | MP0004142_abnormal_muscle_tone | 0.53507126 |
96 | MP0005379_endocrine/exocrine_gland_phen | 0.52371078 |
97 | MP0003045_fibrosis | 0.52074601 |
98 | MP0002254_reproductive_system_inflammat | 0.51688507 |
99 | MP0002928_abnormal_bile_duct | 0.51410854 |
100 | MP0009764_decreased_sensitivity_to | 0.50340701 |
101 | MP0001765_abnormal_ion_homeostasis | 0.50188173 |
102 | MP0001191_abnormal_skin_condition | 0.50016346 |
103 | MP0005451_abnormal_body_composition | 0.49959995 |
104 | MP0010094_abnormal_chromosome_stability | 0.49505557 |
105 | MP0000627_abnormal_mammary_gland | 0.48634830 |
106 | MP0002136_abnormal_kidney_physiology | 0.48202851 |
107 | MP0003091_abnormal_cell_migration | 0.47898167 |
108 | MP0005390_skeleton_phenotype | 0.46817897 |
109 | MP0003252_abnormal_bile_duct | 0.46504285 |
110 | MP0003183_abnormal_peptide_metabolism | 0.45185628 |
111 | MP0000371_diluted_coat_color | 0.45156078 |
112 | MP0004957_abnormal_blastocyst_morpholog | 0.44119828 |
113 | MP0003693_abnormal_embryo_hatching | 0.43763243 |
114 | MP0000367_abnormal_coat/_hair | 0.42618355 |
115 | MP0002693_abnormal_pancreas_physiology | 0.42598696 |
116 | MP0009115_abnormal_fat_cell | 0.42550711 |
117 | MP0000249_abnormal_blood_vessel | 0.42509733 |
118 | MP0005174_abnormal_tail_pigmentation | 0.42206120 |
119 | MP0003221_abnormal_cardiomyocyte_apopto | 0.41912762 |
120 | MP0000350_abnormal_cell_proliferation | 0.41390094 |
121 | MP0002277_abnormal_respiratory_mucosa | 0.41137042 |
122 | MP0003787_abnormal_imprinting | 0.41029719 |
123 | MP0005381_digestive/alimentary_phenotyp | 0.40286075 |
124 | MP0000313_abnormal_cell_death | 0.37414008 |
125 | MP0004185_abnormal_adipocyte_glucose | 0.35869527 |
126 | MP0008873_increased_physiological_sensi | 0.35265309 |
127 | MP0008569_lethality_at_weaning | 0.35241024 |
Rank | Gene Set | Z-score |
---|---|---|
1 | T lymphocytopenia (HP:0005403) | 8.60402390 |
2 | Abnormality of T cell number (HP:0011839) | 8.27353610 |
3 | Severe combined immunodeficiency (HP:0004430) | 6.04477879 |
4 | Abnormality of T cells (HP:0002843) | 5.79830833 |
5 | Combined immunodeficiency (HP:0005387) | 5.58939873 |
6 | Panhypogammaglobulinemia (HP:0003139) | 4.84493996 |
7 | Recurrent bronchitis (HP:0002837) | 4.69204577 |
8 | Nasal polyposis (HP:0100582) | 4.63261678 |
9 | Recurrent fungal infections (HP:0002841) | 4.63174995 |
10 | Myositis (HP:0100614) | 4.61990519 |
11 | Recurrent viral infections (HP:0004429) | 4.56365632 |
12 | Abnormality of B cell number (HP:0010975) | 4.48385560 |
13 | B lymphocytopenia (HP:0010976) | 4.48385560 |
14 | IgM deficiency (HP:0002850) | 4.34393493 |
15 | Retrobulbar optic neuritis (HP:0100654) | 4.29769043 |
16 | Optic neuritis (HP:0100653) | 4.29769043 |
17 | Chronic otitis media (HP:0000389) | 4.11382123 |
18 | Abnormality of eosinophils (HP:0001879) | 4.04957737 |
19 | Eosinophilia (HP:0001880) | 3.91475179 |
20 | Chronic diarrhea (HP:0002028) | 3.87007578 |
21 | Abnormality of the nasal mucosa (HP:0000433) | 3.80577075 |
22 | Thyroiditis (HP:0100646) | 3.76624672 |
23 | Abnormality of the fingertips (HP:0001211) | 3.71344390 |
24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.70471265 |
25 | Orchitis (HP:0100796) | 3.70255500 |
26 | Recurrent bacterial skin infections (HP:0005406) | 3.69690403 |
27 | Autoimmune hemolytic anemia (HP:0001890) | 3.64398376 |
28 | Gastrointestinal infarctions (HP:0005244) | 3.62329072 |
29 | Recurrent cutaneous fungal infections (HP:0011370) | 3.59326042 |
30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.59326042 |
31 | Joint swelling (HP:0001386) | 3.55708947 |
32 | Eczematoid dermatitis (HP:0000976) | 3.55488613 |
33 | * IgG deficiency (HP:0004315) | 3.54944788 |
34 | Leukocytosis (HP:0001974) | 3.52038996 |
35 | Increased IgM level (HP:0003496) | 3.49948841 |
36 | Recurrent abscess formation (HP:0002722) | 3.44749026 |
37 | Abnormality of T cell physiology (HP:0011840) | 3.44641482 |
38 | Increased density of long bones (HP:0006392) | 3.42670854 |
39 | Pustule (HP:0200039) | 3.41933585 |
40 | Granulocytopenia (HP:0001913) | 3.34398042 |
41 | Hemoptysis (HP:0002105) | 3.33711978 |
42 | Pulmonary infiltrates (HP:0002113) | 3.23502228 |
43 | Arterial thrombosis (HP:0004420) | 3.18274674 |
44 | IgA deficiency (HP:0002720) | 3.17928947 |
45 | Lymphopenia (HP:0001888) | 3.17500818 |
46 | Vasculitis (HP:0002633) | 3.15416988 |
47 | Hypoplasia of the thymus (HP:0000778) | 3.10109781 |
48 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.09377527 |
49 | * Stomatitis (HP:0010280) | 3.07388820 |
50 | Keratoconjunctivitis sicca (HP:0001097) | 3.02194505 |
51 | Stomach cancer (HP:0012126) | 3.00961474 |
52 | Meningitis (HP:0001287) | 2.96305075 |
53 | Abnormality of macrophages (HP:0004311) | 2.90261825 |
54 | Persistence of primary teeth (HP:0006335) | 2.90097186 |
55 | Encephalitis (HP:0002383) | 2.85897451 |
56 | Papilledema (HP:0001085) | 2.75104288 |
57 | Autoimmune thrombocytopenia (HP:0001973) | 2.74927706 |
58 | Chest pain (HP:0100749) | 2.73441527 |
59 | Keratoconjunctivitis (HP:0001096) | 2.72165255 |
60 | Mediastinal lymphadenopathy (HP:0100721) | 2.71531345 |
61 | Spontaneous hematomas (HP:0007420) | 2.70498536 |
62 | Pulmonary embolism (HP:0002204) | 2.66010681 |
63 | Bronchitis (HP:0012387) | 2.64796626 |
64 | Thrombocytosis (HP:0001894) | 2.63963984 |
65 | Basal cell carcinoma (HP:0002671) | 2.62091532 |
66 | Increased IgE level (HP:0003212) | 2.57274878 |
67 | Recurrent sinusitis (HP:0011108) | 2.54874812 |
68 | Abnormality of the prostate (HP:0008775) | 2.53495989 |
69 | Ureteral stenosis (HP:0000071) | 2.53117914 |
70 | Inflammation of the large intestine (HP:0002037) | 2.44945031 |
71 | Obstructive lung disease (HP:0006536) | 2.44054588 |
72 | Chronic obstructive pulmonary disease (HP:0006510) | 2.44054588 |
73 | Gangrene (HP:0100758) | 2.40171103 |
74 | Gastrointestinal inflammation (HP:0004386) | 2.39617087 |
75 | Hypochromic anemia (HP:0001931) | 2.38271791 |
76 | Hypergammaglobulinemia (HP:0010702) | 2.36800690 |
77 | * Lymphoma (HP:0002665) | 2.36336457 |
78 | Ureteral obstruction (HP:0006000) | 2.30917925 |
79 | Alveolar cell carcinoma (HP:0006519) | 2.29119015 |
80 | Amaurosis fugax (HP:0100576) | 2.28951196 |
81 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.23277646 |
82 | Hypoproteinemia (HP:0003075) | 2.21553362 |
83 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.21410938 |
84 | Gingivitis (HP:0000230) | 2.20772333 |
85 | Acute hepatic failure (HP:0006554) | 2.19096768 |
86 | Papilloma (HP:0012740) | 2.16238130 |
87 | Verrucae (HP:0200043) | 2.16238130 |
88 | Epistaxis (HP:0000421) | 2.15867778 |
89 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.15389888 |
90 | Chronic sinusitis (HP:0011109) | 2.13549844 |
91 | Slow saccadic eye movements (HP:0000514) | 2.10185173 |
92 | Bronchiectasis (HP:0002110) | 2.06216412 |
93 | Abnormal platelet volume (HP:0011876) | 2.02858704 |
94 | Anorexia (HP:0002039) | 2.01797287 |
95 | Hypochromic microcytic anemia (HP:0004840) | 2.01128976 |
96 | Cheilitis (HP:0100825) | 2.00233011 |
97 | Hemiplegia (HP:0002301) | 1.98556099 |
98 | Gingival bleeding (HP:0000225) | 1.95509573 |
99 | Microcytic anemia (HP:0001935) | 1.95194319 |
100 | Glomerulopathy (HP:0100820) | 1.93880515 |
101 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.91789041 |
102 | Recurrent skin infections (HP:0001581) | 1.89891658 |
103 | Abnormality of the pleura (HP:0002103) | 1.89698975 |
104 | Hepatitis (HP:0012115) | 1.88374022 |
105 | Recurrent otitis media (HP:0000403) | 1.88266183 |
106 | Colitis (HP:0002583) | 1.86535239 |
107 | Prolonged bleeding time (HP:0003010) | 1.85635569 |
108 | Fatigue (HP:0012378) | 1.84295092 |
109 | Emphysema (HP:0002097) | 1.81944853 |
110 | Urticaria (HP:0001025) | 1.81614455 |
111 | Genetic anticipation (HP:0003743) | 1.80254936 |
112 | Gastrointestinal stroma tumor (HP:0100723) | 1.79156363 |
113 | Episodic fever (HP:0001954) | 1.79080127 |
114 | Polyneuropathy (HP:0001271) | 1.78560628 |
115 | Hematochezia (HP:0002573) | 1.77587264 |
116 | Arthralgia (HP:0002829) | 1.76722478 |
117 | Dislocated radial head (HP:0003083) | 1.76046537 |
118 | Agammaglobulinemia (HP:0004432) | 1.75568710 |
119 | Keratitis (HP:0000491) | 1.75305635 |
120 | Diplopia (HP:0000651) | 1.74443192 |
121 | Abnormality of binocular vision (HP:0011514) | 1.74443192 |
122 | Abnormality of the endocardium (HP:0004306) | 1.74392353 |
123 | * Elevated erythrocyte sedimentation rate (HP:0003565) | 1.74011620 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 7.43742928 |
2 | MAP4K1 | 6.05594654 |
3 | JAK3 | 3.52474082 |
4 | ZAP70 | 3.30495132 |
5 | FGFR4 | 2.87523186 |
6 | * ITK | 2.73063324 |
7 | STK10 | 2.63470108 |
8 | MAP3K14 | 2.46072947 |
9 | IKBKE | 2.40297396 |
10 | RIPK4 | 2.37874737 |
11 | TYK2 | 2.31354342 |
12 | NLK | 2.21940159 |
13 | CAMKK2 | 2.18574621 |
14 | GRK6 | 2.16918817 |
15 | FGFR3 | 2.02128356 |
16 | PRPF4B | 1.99697760 |
17 | JAK1 | 1.87630142 |
18 | * LCK | 1.76072726 |
19 | EEF2K | 1.72172684 |
20 | CSK | 1.64138573 |
21 | CAMKK1 | 1.58764812 |
22 | MST4 | 1.55996082 |
23 | FRK | 1.55733130 |
24 | MAP3K10 | 1.47035598 |
25 | TBK1 | 1.41454324 |
26 | SYK | 1.34619846 |
27 | IKBKB | 1.33619140 |
28 | PRKCQ | 1.28158069 |
29 | PRKCH | 1.25376774 |
30 | MAP3K13 | 1.24227061 |
31 | CHUK | 1.23112401 |
32 | PIM1 | 1.12985881 |
33 | * HCK | 1.11591854 |
34 | CDK12 | 1.11180811 |
35 | MARK3 | 1.07663128 |
36 | MAP3K7 | 1.07044316 |
37 | JAK2 | 1.04282123 |
38 | NME2 | 1.03265849 |
39 | PKN2 | 1.01781775 |
40 | TSSK6 | 1.00720138 |
41 | PIK3CG | 1.00339125 |
42 | TYRO3 | 0.99875176 |
43 | TAOK1 | 0.98319982 |
44 | RPS6KA4 | 0.97031639 |
45 | EPHA3 | 0.96868758 |
46 | LRRK2 | 0.88221456 |
47 | EPHB1 | 0.86919525 |
48 | SIK2 | 0.81176209 |
49 | MAP2K3 | 0.76882031 |
50 | CLK1 | 0.76191442 |
51 | PDGFRB | 0.75804447 |
52 | TGFBR2 | 0.73359354 |
53 | IRAK4 | 0.73226816 |
54 | TRIB3 | 0.67531262 |
55 | CDK4 | 0.66546639 |
56 | BRD4 | 0.66323431 |
57 | BLK | 0.65859465 |
58 | TNK2 | 0.65231845 |
59 | MELK | 0.64806500 |
60 | SIK3 | 0.64709132 |
61 | FGFR1 | 0.62866252 |
62 | FES | 0.62816180 |
63 | KDR | 0.61216656 |
64 | KIT | 0.60372595 |
65 | ADRBK2 | 0.60061792 |
66 | LYN | 0.59943067 |
67 | SGK2 | 0.59717966 |
68 | MARK2 | 0.59449882 |
69 | BMPR2 | 0.58185588 |
70 | NEK6 | 0.57606925 |
71 | MAP3K1 | 0.55008432 |
72 | ALK | 0.54928868 |
73 | FGR | 0.54837600 |
74 | IRAK1 | 0.53573640 |
75 | MAP3K11 | 0.52335640 |
76 | HIPK2 | 0.52056158 |
77 | CSF1R | 0.50765840 |
78 | MAP2K6 | 0.50574831 |
79 | TESK2 | 0.50365751 |
80 | NUAK1 | 0.49057558 |
81 | PDK1 | 0.48459069 |
82 | PASK | 0.48312392 |
83 | RPS6KA5 | 0.46533909 |
84 | PRKD2 | 0.46398672 |
85 | MAPK7 | 0.45810669 |
86 | CDK9 | 0.43204368 |
87 | STK38 | 0.42913100 |
88 | * BTK | 0.42139073 |
89 | PIM2 | 0.41362660 |
90 | CAMK4 | 0.40827609 |
91 | TRPM7 | 0.40479152 |
92 | TTN | 0.40023443 |
93 | IGF1R | 0.39155545 |
94 | TAOK3 | 0.38068617 |
95 | WNK1 | 0.37809273 |
96 | GRK7 | 0.36220804 |
97 | FGFR2 | 0.35895094 |
98 | YES1 | 0.35659910 |
99 | STK4 | 0.35414261 |
100 | STK11 | 0.34560356 |
101 | CDK6 | 0.34547067 |
102 | FYN | 0.34263046 |
103 | MAP3K3 | 0.34123080 |
104 | PTK2B | 0.33624367 |
105 | PTK6 | 0.32906250 |
106 | MAP3K8 | 0.32555852 |
107 | NTRK2 | 0.32051416 |
108 | RAF1 | 0.31577887 |
109 | IRAK3 | 0.30467279 |
110 | * INSR | 0.29172636 |
111 | MAPK3 | 0.27852998 |
112 | SGK3 | 0.27542667 |
113 | TGFBR1 | 0.27059769 |
114 | SGK223 | 0.25737941 |
115 | SGK494 | 0.25737941 |
116 | MAPK4 | 0.25172315 |
117 | * TEC | 0.24778304 |
118 | DMPK | 0.24474309 |
119 | RPS6KA6 | 0.22890790 |
120 | RPS6KA1 | 0.22391325 |
121 | EGFR | 0.21717918 |
122 | MAPK12 | 0.21016953 |
123 | MAPKAPK2 | 0.20855067 |
124 | TAOK2 | 0.20591881 |
125 | ROCK2 | 0.19708416 |
126 | STK24 | 0.18919723 |
127 | MAPK11 | 0.17694817 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.35853126 |
2 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.10510232 |
3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.56734064 |
4 | Allograft rejection_Homo sapiens_hsa05330 | 3.37970975 |
5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.13491777 |
6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.89994416 |
7 | Measles_Homo sapiens_hsa05162 | 2.85940682 |
8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.78973854 |
9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.76310861 |
10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.63225625 |
11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.35642648 |
12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.05605465 |
13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.99581424 |
14 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.97304093 |
15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.87509218 |
16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.76847551 |
17 | Asthma_Homo sapiens_hsa05310 | 1.69159039 |
18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.67698675 |
19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.51962531 |
20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.51634246 |
21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.49727309 |
22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.49492040 |
23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44067649 |
24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.34772948 |
25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.34771210 |
26 | Hepatitis B_Homo sapiens_hsa05161 | 1.30994676 |
27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.30712917 |
28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.29195451 |
29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28672142 |
30 | HTLV-I infection_Homo sapiens_hsa05166 | 1.23090144 |
31 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.19770894 |
32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19249015 |
33 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15770545 |
34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.12161868 |
35 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.11285928 |
36 | Influenza A_Homo sapiens_hsa05164 | 1.09935162 |
37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00479605 |
38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.00200005 |
39 | Colorectal cancer_Homo sapiens_hsa05210 | 0.98409674 |
40 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98299671 |
41 | Shigellosis_Homo sapiens_hsa05131 | 0.96313598 |
42 | Apoptosis_Homo sapiens_hsa04210 | 0.92937700 |
43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.90712975 |
44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89016958 |
45 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88633724 |
46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85152224 |
47 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84082989 |
48 | Legionellosis_Homo sapiens_hsa05134 | 0.83320376 |
49 | Hepatitis C_Homo sapiens_hsa05160 | 0.79838176 |
50 | Platelet activation_Homo sapiens_hsa04611 | 0.72501798 |
51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70773764 |
52 | Malaria_Homo sapiens_hsa05144 | 0.69212262 |
53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66340203 |
54 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.66263889 |
55 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63852050 |
56 | Spliceosome_Homo sapiens_hsa03040 | 0.63685451 |
57 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62620991 |
58 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.61032698 |
59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60724914 |
60 | Tuberculosis_Homo sapiens_hsa05152 | 0.60610134 |
61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58789760 |
62 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58774186 |
63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57926359 |
64 | Thyroid cancer_Homo sapiens_hsa05216 | 0.57729352 |
65 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56651978 |
66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56602843 |
67 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.55675498 |
68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54706803 |
69 | Circadian rhythm_Homo sapiens_hsa04710 | 0.54464947 |
70 | Ribosome_Homo sapiens_hsa03010 | 0.54328778 |
71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53813392 |
72 | Salmonella infection_Homo sapiens_hsa05132 | 0.53358007 |
73 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49664744 |
74 | Prostate cancer_Homo sapiens_hsa05215 | 0.48840062 |
75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48367295 |
76 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.47888985 |
77 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.47000226 |
78 | RNA degradation_Homo sapiens_hsa03018 | 0.45173312 |
79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.45136451 |
80 | Pertussis_Homo sapiens_hsa05133 | 0.44896119 |
81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43293893 |
82 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42918573 |
83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42765675 |
84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42519194 |
85 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.42256381 |
86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40812608 |
87 | Endocytosis_Homo sapiens_hsa04144 | 0.40676367 |
88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40072591 |
89 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38138831 |
90 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37939384 |
91 | Insulin resistance_Homo sapiens_hsa04931 | 0.36702690 |
92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.35479736 |
93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35407562 |
94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34398603 |
95 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.34054154 |
96 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.32626649 |
97 | ABC transporters_Homo sapiens_hsa02010 | 0.31983034 |
98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31860286 |
99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30898820 |
100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30381826 |
101 | Pathways in cancer_Homo sapiens_hsa05200 | 0.30073973 |
102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29595803 |
103 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.29424025 |
104 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28773380 |
105 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.27999198 |
106 | Long-term potentiation_Homo sapiens_hsa04720 | 0.26320206 |
107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.25827437 |
108 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.24181630 |
109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.24131083 |
110 | Morphine addiction_Homo sapiens_hsa05032 | 0.23110958 |
111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.22979836 |
112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.22889738 |
113 | RNA transport_Homo sapiens_hsa03013 | 0.21318974 |
114 | Adherens junction_Homo sapiens_hsa04520 | 0.20714664 |
115 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.20675630 |
116 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.20345653 |
117 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.20046508 |
118 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.18033703 |
119 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.17384870 |
120 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.16863697 |
121 | Base excision repair_Homo sapiens_hsa03410 | 0.16153251 |
122 | Lysine degradation_Homo sapiens_hsa00310 | 0.14302572 |